HealthEquity Inc.
HealthEquity Inc. is listed today as HealthEquity, Inc.: market value, financials and filings are on its company page.
Funding rounds
0 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Aug 2011 | $13 M | Issued in a merger or acquisition | $10 to $50 million | equity, debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company HealthEquity, Inc., its revenue in fiscal 2026 came from these product and service lines: Custodial $636.80 million (48%), Interchange $191.61 million (15%).
Annual report (SEC XBRL) · Jan 2026
HealthEquity Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2011).
SEC Form D · Sep 2011
The industry group it chose in its notices: Other Technology.
SEC Form D · Sep 2011
Products and services#
No products or services of HealthEquity Inc. are on record.
Investors#
8 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Berkley Capital Investors, L.P. | Fund or asset manager | not stated | not stated | Held Series C, D-1, D-2 and D-3 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Berkley Capital, LLC | Fund or asset manager | not stated | not stated | Held Series C, D-1, D-2 and D-3 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Ernest H. Pomerantz | Person | not stated | not stated | Held Series B, C and D-1 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Financial Partners Fund I, L.P. | Fund or asset manager | not stated | not stated | Held Series D-3 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Napier Park Global Capital GP LLC | Fund or asset manager | not stated | not stated | Held Series D-3 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Pinnacle Health III, LLC | Other | not stated | not stated | Held Series C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Sandra Pershing | Person | not stated | not stated | Held Series D-1 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Stephen Neeleman | Person | not stated | not stated | Held Series B and D-1 preferred stock, 10% owner, director (Form 3, 2014) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.
Largest shareholders today
Institutions holding HealthEquity, Inc. shares, as of Sep 30, 2026.
- BlackRock, Inc.$1000 M13.66%
- Wasatch Advisors LP$620 M8.48%
- Vanguard Portfolio Management LLC$350 M4.78%
- Morgan Stanley$337 M4.60%
- Vanguard Capital Management LLC$316 M4.32%
- State Street Corp$287 M3.92%
- Geode Capital Management, LLC$206 M2.81%
- Dimensional Fund Advisors LP$168 M2.29%
- William Blair Investment Management, LLC$154 M2.10%
- Arrowstreet Capital, Limited Partnership$134 M1.83%
- Price T Rowe Associates Inc /MD/$129 M1.76%
- Westfield Capital Management Co LP$127 M1.74%
- Swedbank AB$124 M1.70%
- Bank Of America Corp /de/$124 M1.69%
- Goldman Sachs Group Inc$114 M1.55%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Darcy Mott | Executive officer | Sep 2011 |
| Jon Kessler | Executive officer | Sep 2011 |
| Mike Chapman | Executive officer | Sep 2011 |
| Stephen Neeleman | Executive officer | Sep 2011 |
| Steve Lindsay | Executive officer | Sep 2011 |
| Tessa White | Executive officer | Sep 2011 |
| Dan Kittredge | Director | Sep 2011 |
| Frank Medici | Director | Sep 2011 |
| Ian Sacks | Director | Sep 2011 |
| Jon Kessler | Director | Sep 2011 |
| Kenneth Wooley | Director | Sep 2011 |
| Michael O. Leavitt | Director | Sep 2011 |
| Stephen Neeleman | Director | Sep 2011 |
Went public since 2014. Its SEC number is that of a company listed on a stock exchange.